이상반응 보고
| VAERS ID | 2013930 |
|---|---|
| 성별 | 남성 |
| 나이 | 86세 |
| 주 코드 | MI |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | ER8734 |
| 예방접종 횟수 | 2 |
| 접종일 | 2021-04-01 |
| 발병일 | 2021-11-09 |
| 상태 | 입원 중증 사망 |
증상
- 설사(Diarrhoea)
- 집중 치료(Intensive care)
- 복통(Abdominal pain)
- SARS-CoV-2 테스트 양성(SARS-CoV-2 test positive)
- 코로나 바이러스 감염증 -19 : 코로나 19(COVID-19)
- 심방 세동(Atrial fibrillation)
- 헤모글로빈 감소(Haemoglobin decreased)
- 급성 신장 손상(Acute kidney injury)
- 섬유소 D 이량체 증가(Fibrin D dimer increased)
- 기계적 환기(Mechanical ventilation)
- 죽음(Death)
- 급성 호흡 부전(Acute respiratory failure)
- 패혈성 쇼크(Septic shock)
- 항응고 요법(Anticoagulant therapy)
- 주입(Transfusion)
- 전해질 불균형(Electrolyte imbalance)
- 정상적혈구빈혈(Normocytic anaemia)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
COVID 19 virus positive on 11/9/2021.
Admitting dx: abdominal pain, AKI, COVID infection.
Patient presented with acute respiratory failure and diarrhea.
Patient is status post started on remdesivir and IV hydration correction of electrolyte imbalance and patient condition continued to be worsening.
Patient diagnosed with COVID and started on the COVID treatment but the patient continued to be worsening status post into patient with acute kidney injury.
Family opted for the patient to be transitioned to hospice care and comfort care and plan for the patient to be taken off the ventilator with gradual wean.
Positive D dimer.
Treatment: remdesivir, decadron, albuterol nebulizer, inbulation and sedated on full vent support.
Septic shock: Levophed, ICU management, IV antibiotics.
Afib with rapid ventricular response: IV Cardizem drip, IV heparin, metoprolol.
Normocytic anemia requiring 2 units of blood for HG less than 7.
Pt expired.